3rd Quarter - Report

THE NICKLES GROUP, LLC for UCB, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Issues related to access to home infusion, including H.R. 993, Joe Fiandra Access to Home infusion Act of 2025. H.R. 946/S.1862, ORPHAN Cures Act. H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to drug pricing and pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.

LobbyistCovered position, as disclosed
BRETT BAKER —
GREG D'ANGELO —
MARY BETH SAVARY TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (119th), H.R. 946 (119th), H.R. 993 (119th), S. 1862 (119th)

Taxation/Internal Revenue Code TAX

Issues related to the Orphan Drug Tax Credit. H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes.

LobbyistCovered position, as disclosed
RACHEL JONES HENSLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (119th)

Health Issues HCR

Issues related to medication step therapy. S.864, HELP Copays Act, as it relates to out-of-pocket costs for prescription drugs. Issues related to pharmacy benefit management reforms.

LobbyistCovered position, as disclosed
BRETT BAKER —
GREG D'ANGELO —
MARY BETH SAVARY TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 864 (119th)

Trade (domestic/foreign) TRD

Issues related to tariffs.

LobbyistCovered position, as disclosed
GREG D'ANGELO —
RACHEL JONES HENSLER —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.